Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA
Dr Dickler talks to ecancertv at AACR 2015 about a new investigational oestrogen receptor (ER) degrader GDC-0810 that is safe and tolerable in postmenopausal women with advanced ER-positive breast cancer.
A subset of the...
Published 10/31/15
Dr Nilsson talks to ecancertv at AACR 2015 about the development of a blood test which regularly monitors for the presence of the rearrangement of the EML4-ALK gene fusion in patients with non-small cell lung cancer (NSCLC), helping clinicians predict the outcome of treatment with crizotinib.
Published 10/31/15